1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Aspergillosis: new trials by email Literature Review of Aspergillosis trials Research Report on Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection Posaconazole 100 MG [Noxafil], Posaconazole 40 MG/ML - Cystic Fibrosis, Aspergillosis | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 135 | 2021-04-22 | 2021-07-19 |
Cystic Fibrosis (1) · Reinfection (1)
Bacterial Infections and Mycoses (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Disease Attributes (1) · Genetic Diseases, Inborn (1) · Infant, Newborn, Diseases (1) · Infections (1) · Lung Diseases (1) · Mycoses (1) · Pancreatic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Recurrence (1) · Respiratory Tract Diseases (1)
Suspensions (1) · posaconazole (1)
Bambino Gesù Hospital and Research Institute (1)
Czechia (1) · France (1) · Germany (1) · Greece (1) · Ireland (1) · Italy (1) · Netherlands (1) · Portugal (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
2019 (1)